SCHEMBL2774471

SCHEMBL2774471

O=S1(=O)N=CN(C2CC2)c2cc(Cl)ccc21

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GRIA1 P42261 5/20 0.42
GRIA2 P42262 5/20 0.42
GRIA3 P42263 5/20 0.42
GRIA4 P48058 5/20 0.42
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
CA2 P00918 2/20 0.33
CA1 P00915 1/20 0.33
SRD5A1 P18405 4/20 0.32
ABCC8 Q09428 1/20 0.32
KCNJ11 Q14654 1/20 0.32
NOTUM Q6P988 2/20 0.32
CA12 O43570 1/20 0.31
CA4 P22748 1/20 0.31
CA7 P43166 1/20 0.31
CA9 Q16790 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
MAT2A P31153 1/20 0.31
HRH3 Q9Y5N1 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2777124 0.94 GRIA1 (0.37) GRIA1GRIA2GRIA3GRIA4MEN1
SCHEMBL2777423 0.94 GRIA1 (0.37) GRIA1GRIA2GRIA3GRIA4MEN1
SCHEMBL2777275 0.93 GRIA1 (0.36) GRIA1GRIA2GRIA3GRIA4MEN1
SCHEMBL2779292 0.93 GRIA1 (0.36) GRIA1GRIA2GRIA3GRIA4MEN1
SCHEMBL2777136 0.93 GRIA1 (0.36) GRIA1GRIA2GRIA3GRIA4MEN1
SCHEMBL2777517 0.88 GRIA2 (0.48) GRIA1GRIA2GRIA3GRIA4CA2
SCHEMBL2776716 0.83 GRIA2 (0.43) GRIA1GRIA2GRIA3GRIA4CA2
SCHEMBL2777425 0.83 GRIA2 (0.43) GRIA1GRIA2GRIA3GRIA4CA2
SCHEMBL2776609 0.82 CHRNA1 (0.33) GRIA2MEN1KMT2ACA2CA1
SCHEMBL2775935 0.82 GRIA2 (0.48) GRIA1GRIA2GRIA3GRIA4MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2147915-B1 New cycloalkylated benzothiadiazine derivatives, method of preparing same and pharmaceutical compositions containing them SERVIER LAB (FR) 2010-09-15 EP disclosed
US-7741320-B2 Cycloalkylated benzothiadiazines, a process for their preparation and pharmaceutical compositions containing them LES LABORATOIRES SERVIER (FR) 2010-06-22 US disclosed
EP-2147915-A1 New cycloalkylated benzothiadiazine derivatives, method of preparing same and pharmaceutical compositions containing them Les Laboratoires Servier (FR) 2010-01-27 EP disclosed
US-20100009974-A1 Cycloalkylated benzothiadiazines, a process for their preparation and pharmaceutical compostions containing them LES LABORATOIRES SERVIER (FR) 2010-01-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100009974-A1 Cycloalkylated benzothiadiazines, a process for their preparation and pharmaceutical compostions containing them ACLY, HCAR1, GABRG1 GRIA1 68/4885GRIA2 116/4885GRIA3 126/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.